MeiraGTx Holdings PLC

MGTX

Company Profile

  • Business description

    MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

  • Contact

    450 East 29th Street
    14th Floor
    New YorkNY10016
    USA

    T: +1 646 860-7985

    https://www.meiragtx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    386

Stocks News & Analysis

stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.
stocks

Coca-Cola earnings: Innovation and brand strength underpin growth

We plan to raise our fair value estimate of Coca-Cola stock.
stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,390.1016.400.17%
CAC 408,258.8652.790.64%
DAX 4024,330.0371.230.29%
Dow JONES (US)46,924.74218.160.47%
FTSE 1009,426.9923.420.25%
HKSE26,027.55168.720.65%
NASDAQ22,953.6736.88-0.16%
Nikkei 22549,316.06130.560.27%
NZX 50 Index13,324.0253.83-0.40%
S&P 5006,735.350.220.00%
S&P/ASX 2009,094.7018.800.21%
SSE Composite Index3,916.3352.441.36%

Market Movers